This event will bring together representatives of international regulatory organizations to jointly address and better understand the global regulatory challenges in the development, manufacture, and access of products to treat rare diseases. Current global policies/strategies will also be discussed.
By convening regulators from all major government agencies in North America, Europe, Asia, Australia, South & Central America, and Africa, the objective is to facilitate knowledge sharing, discussion, and connections with like-minded agencies to not only help pave the way for tackling the regulatory challenges in rare disease space but also advancing/accelerating the translation and development of treatments for rare diseases.
In addition to agency regulators, members of ISCT scientific thought leadership will participate and contribute to the discussions.